- Home
- TCBS vs ONCY Comparison
TCBS vs ONCY Comparison
Compare TCBS & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- ONCY
- Stock Information
- Founded
- TCBS 1934
- ONCY 1998
- Country
- TCBS United States
- ONCY Canada
- Employees
- TCBS N/A
- ONCY N/A
- Industry
- TCBS Banks
- ONCY Pharmaceuticals and Biotechnology
- Sector
- TCBS Finance
- ONCY Health Care
- Exchange
- TCBS Nasdaq
- ONCY Nasdaq
- Market Cap
- TCBS 50.1M
- ONCY 53.6M
- IPO Year
- TCBS N/A
- ONCY 1999
- Fundamental
- Price
- TCBS $16.00
- ONCY $0.54
- Analyst Decision
- TCBS
- ONCY Strong Buy
- Analyst Count
- TCBS 0
- ONCY 4
- Target Price
- TCBS N/A
- ONCY $4.00
- AVG Volume (30 Days)
- TCBS 4.2K
- ONCY 215.9K
- Earning Date
- TCBS 05-13-2025
- ONCY 03-07-2025
- Dividend Yield
- TCBS 1.00%
- ONCY N/A
- EPS Growth
- TCBS N/A
- ONCY N/A
- EPS
- TCBS N/A
- ONCY N/A
- Revenue
- TCBS $10,489,000.00
- ONCY N/A
- Revenue This Year
- TCBS N/A
- ONCY N/A
- Revenue Next Year
- TCBS N/A
- ONCY N/A
- P/E Ratio
- TCBS N/A
- ONCY N/A
- Revenue Growth
- TCBS N/A
- ONCY N/A
- 52 Week Low
- TCBS $13.51
- ONCY $0.53
- 52 Week High
- TCBS $17.50
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- TCBS 46.78
- ONCY 26.43
- Support Level
- TCBS $15.70
- ONCY $0.58
- Resistance Level
- TCBS $16.25
- ONCY $0.65
- Average True Range (ATR)
- TCBS 0.21
- ONCY 0.03
- MACD
- TCBS -0.06
- ONCY -0.00
- Stochastic Oscillator
- TCBS 23.08
- ONCY 1.36
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.